Köbberling Type of Familial Partial Lipodystrophy
- 1 June 2003
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (6), 1819-1824
- https://doi.org/10.2337/diacare.26.6.1819
Abstract
OBJECTIVE—The phenotypic expression of partial lipodystrophy is present in two familial syndromes: familial partial lipodystrophy type 1 (FPLD1), with fat loss from the extremities, and central obesity and FPLD type 2, with fat loss from the extremities, abdomen, and thorax. The latter disorder is associated with mutations in the LMNA gene. FPLD1 is thought to be rare. Here, we report 13 subjects with FPLD1, suggesting that this syndrome is more common than previously thought. RESEARCH DESIGN AND METHODS—Fasting glucose, plasma lipids, leptin, HbA1c, and anthropomorphic measurements were evaluated in 13 subjects with clinical features of FPLD1 and are compared with two age-matched control groups, with and without diabetes. RESULTS—Only women with clinical features of FPLD1 have been identified. Although they lack extremity and gluteal subcutaneous fat, they do have truncal obesity. Skinfold thickness on the arm and leg was significantly less than that in control subjects. The ratio of skinfold thickness from abdomen to thigh was significantly higher in subjects, suggesting an easy method for identifying affected patients. FPLD1 subjects also had components of the metabolic syndrome, including hypertension, insulin resistance, and severe hypertriglyceridemia resulting in pancreatitis. Premature coronary artery disease was present in 31% of subjects. None of the subjects had coding mutations in the LMNA gene or in the gene coding for peroxisome proliferator-activated receptor (PPAR)-γ. CONCLUSIONS—FPLD1 is more common than previously described, but the diagnosis is often missed. Early recognition and intensive treatment of hyperlipidemia and diabetes in FPLD1 is important for prevention of pancreatitis and early cardiovascular disease.This publication has 27 references indexed in Scilit:
- Dyslipemia in Familial Partial Lipodystrophy Caused by an R482W Mutation in the LMNA GeneJournal of Clinical Endocrinology & Metabolism, 2001
- Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor γ resistanceBiochemical Society Transactions, 2001
- LMNA, encoding lamin A/C, is mutated in partial lipodystrophyNature Genetics, 2000
- Adipose Tissue Distribution Pattern in Patients with Familial Partial Lipodystrophy (Dunnigan Variety)Journal of Clinical Endocrinology & Metabolism, 1999
- Partial face‐sparing lipodystrophy (Köbberling‐Dunnigan syndrome): Report of a sporadic caseAustralasian Journal of Dermatology, 1998
- Effect of Regional Fat Distribution and Prader-Willi Syndrome on Plasma Leptin LevelsJournal of Clinical Endocrinology & Metabolism, 1997
- Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophyQJM: An International Journal of Medicine, 1997
- An unusual type of familial lipodystrophyJournal of Clinical Endocrinology & Metabolism, 1995
- LIPODYSTROPHY WITH HYPERLIPIDAEMIA: THE ROLE OF INSULIN IN VERY LOW DENSITY LIPOPROTEIN OVER-SYNTHESISClinical Endocrinology, 1979
- Metabolic studies in familial partial lipodystrophy of the lower trunk and extremitiesDiabetologia, 1975